COMP <GO>
TNC vs TMO // RETURN ON INVESTED CAPITAL (ROIC)
Tennant Company (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: TNC 4
— TMO 8
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: TMO
LAST: $66.64 (+0.83%) • MKT CAP: $1.14B
roic
9.00%
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
roic
9.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TNC VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TNC | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 40.20% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 9.00% | 9.30% | -0.30 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 13.1x | 30.4x | -17.30 | TNC | /valuation <GO> |
| Free Cash Flow Yield | 3.81% | 2.40% | +1.41 | TNC | /fcf-yield <GO> |
| Operating Margin | 5.70% | 17.40% | -11.70 | TMO | /operating-margins <GO> |
| Net Profit Margin | 3.60% | 15.10% | -11.50 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | -6.50% | 3.90% | -10.40 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.93% | 0.24% | +1.69 | TNC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.13 | 4.50 | -1.37 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.4 | 62.9 | -14.55 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 24.1x | 36.3x | -12.20 | TNC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.14B | $262.22B | -$261.08B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TNC REV | TMO REV | TNC GROSS % | TMO GROSS % | TNC FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.20B | $44.56B | 40.2% | — | $43.3M | $6.29B |
| FY 2024 | $1.29B | $42.88B | 42.7% | — | $68.8M | $7.27B |
| FY 2023 | $1.24B | $42.86B | — | — | $188.4M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TNC // BETA —
TMO // BETA 0.94